- Home
- PAAS vs MEDP Comparison
PAAS vs MEDP Comparison
Compare PAAS & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAAS
- MEDP
- Stock Information
- Founded
- PAAS 1994
- MEDP 1992
- Country
- PAAS Canada
- MEDP United States
- Employees
- PAAS N/A
- MEDP N/A
- Industry
- PAAS
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- Sector
- PAAS
- MEDP Health Care
- Exchange
- PAAS Nasdaq
- MEDP Nasdaq
- Market Cap
- PAAS 15.0B
- MEDP 13.4B
- IPO Year
- PAAS 1995
- MEDP 2016
- Fundamental
- Price
- PAAS $37.58
- MEDP $607.00
- Analyst Decision
- PAAS Strong Buy
- MEDP Hold
- Analyst Count
- PAAS 3
- MEDP 11
- Target Price
- PAAS $45.67
- MEDP $451.70
- AVG Volume (30 Days)
- PAAS 5.7M
- MEDP 337.9K
- Earning Date
- PAAS 11-12-2025
- MEDP 10-22-2025
- Dividend Yield
- PAAS 1.12%
- MEDP N/A
- EPS Growth
- PAAS N/A
- MEDP 25.36
- EPS
- PAAS 1.44
- MEDP 14.32
- Revenue
- PAAS $3,116,300,000.00
- MEDP $2,358,373,000.00
- Revenue This Year
- PAAS $21.54
- MEDP $21.48
- Revenue Next Year
- PAAS $9.98
- MEDP $11.90
- P/E Ratio
- PAAS $26.10
- MEDP $42.51
- Revenue Growth
- PAAS 21.09
- MEDP 13.88
- 52 Week Low
- PAAS $19.80
- MEDP $250.05
- 52 Week High
- PAAS $42.57
- MEDP $625.00
- Technical
- Relative Strength Index (RSI)
- PAAS 56.11
- MEDP 68.95
- Support Level
- PAAS $33.62
- MEDP $573.07
- Resistance Level
- PAAS $36.24
- MEDP $602.54
- Average True Range (ATR)
- PAAS 1.16
- MEDP 20.39
- MACD
- PAAS 0.13
- MEDP -0.47
- Stochastic Oscillator
- PAAS 95.78
- MEDP 65.24
About PAAS Pan American Silver Corp.
Pan American Silver Corp is a mining company principally engaged in the operation and development of, and exploration for, silver and gold-producing properties and assets. The company's principal products are silver and gold, although it also produces and sells zinc, lead, and copper. Its operating mines comprise La Colorada, Dolores, Huaron, Morococha, Shahuindo, La Arena, Timmins West, Bell Creek, Manantial Espejo, and San Vicente mines.
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.